An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level

被引:15
作者
Daniels, RS
Kang, C
Patel, D
Xiang, Z
Douglas, NW
Zheng, NN
Cho, HW
Lee, JS
机构
[1] Natl Inst Med Res, Div Virol, London NW7 1AA, England
[2] Natl Inst Hlth, Dept Virol, Seoul 122701, South Korea
关键词
D O I
10.1089/088922203322280847
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-1 subtype B predominates in the Republic of Korea. Phylogenetic analyses of sequences for complete nef genes and env gene fragments encoding the V3 loop have identified a major monophyletic Korean subclade that is distinct from Western subtype B sequences in the Los Alamos HIV Sequence Database. This was investigated further by sequence analysis of complete env genes recovered from the DNA of peripheral blood mononuclear cells for matched groups of Koreans, four patients per group, previously assigned as being infected with either Korean or Western strains. The phylogenetic classifications were confirmed and analysis of the translation products identified 32 amino acid signature pattern differences, dispersed throughout gp160, which differentiate the two subclades. Twenty-three of these positions map to epitopes recognized by HLA-I-restricted cytotoxic T-lymphocytes (CTL) as catalogued in the Los Alamos HIV Immunology Database. The remaining nine map at or close to sites predicted to be targets for immunoproteasomes that are involved in producing peptides that bind to MHC Class I. These results suggest that a founder effect in the Korean population is based on the spread of CTL-escape/host-adapted HIV-1 strains.
引用
收藏
页码:631 / 641
页数:11
相关论文
共 68 条
[1]   Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution [J].
Bagnarelli, P ;
Mazzola, F ;
Menzo, S ;
Montroni, M ;
Butini, L ;
Clementi, M .
JOURNAL OF VIROLOGY, 1999, 73 (05) :3764-3777
[2]   Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site [J].
Beekman, NJ ;
van Veelen, PA ;
van Hall, T ;
Neisig, A ;
Sijts, A ;
Camps, M ;
Kloetzel, PM ;
Neefjes, JJ ;
Melief, CJ ;
Ossendorp, F .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1898-1905
[3]   HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades [J].
Bird, TG ;
Kaul, R ;
Rostron, T ;
Kimani, J ;
Embree, J ;
Dunn, PPJ ;
Bwayo, JJ ;
Plummer, FA ;
Rowland-Jones, SL ;
Dong, T .
AIDS, 2002, 16 (14) :1899-1904
[4]   An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected thais [J].
Bond, KB ;
Sriwanthana, B ;
Hodge, TW ;
De Groot, AS ;
Mastro, TD ;
Young, NL ;
Promadej, N ;
Altman, JD ;
Limpakarnjanarat, K ;
McNicholl, JM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (08) :703-717
[5]   A new DNA sequence assembly program [J].
Bonfield, JK ;
Smith, KF ;
Staden, R .
NUCLEIC ACIDS RESEARCH, 1995, 23 (24) :4992-4999
[6]   Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [J].
Borrow, P ;
Lewicki, H ;
Wei, XP ;
Horwitz, MS ;
Peffer, N ;
Meyers, H ;
Nelson, JA ;
Gairin, JE ;
Hahn, BH ;
Oldstone, MBA ;
Shaw, GM .
NATURE MEDICINE, 1997, 3 (02) :205-211
[7]   Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: Implications for virus evolution [J].
Burrows, JM ;
Burrows, SR ;
Poulsen, LM ;
Sculley, TB ;
Moss, DJ ;
Khanna, R .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2490-2496
[8]  
Caffrey DR, 2000, PROTEIN SCI, V9, P655
[9]   HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].
Carrington, M ;
Nelson, GW ;
Martin, MP ;
Kissner, T ;
Vlahov, D ;
Goedert, JJ ;
Kaslow, R ;
Buchbinder, S ;
Hoots, K ;
O'Brien, SJ .
SCIENCE, 1999, 283 (5408) :1748-1752
[10]   Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage [J].
Cecilia, D ;
Kewalramani, VN ;
O'Leary, J ;
Volsky, B ;
Nyambi, P ;
Burda, S ;
Xu, S ;
Littman, DR ;
Zolla-Pazner, S .
JOURNAL OF VIROLOGY, 1998, 72 (09) :6988-6996